Since lower expression of TET2 in mononuclear cells was detected in >86% of inflammation‐associated PAH cases (Potus et al., 2020), our findings suggest higher TET2 expression in PAH patients with scleroderma was somewhat perplexing and surprising to us. Here, TET2 is linked to pulmonary arterial hypertension.